170 related articles for article (PubMed ID: 21756236)
1. Treating benign prostatic hyperplasia with botulinum neurotoxin.
Brisinda G; Vanella S; Marniga G; Crocco A; Maria G
Curr Med Chem; 2011; 18(23):3468-75. PubMed ID: 21756236
[TBL] [Abstract][Full Text] [Related]
2. Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin.
Maria G; Cadeddu F; Brisinda D; Brandara F; Brisinda G
Curr Med Chem; 2005; 12(3):247-65. PubMed ID: 15723617
[TBL] [Abstract][Full Text] [Related]
3. Perspective of Botox for treatment of male lower urinary tract symptoms.
Ilie CP; Chancellor MB
Curr Opin Urol; 2009 Jan; 19(1):20-5. PubMed ID: 19057212
[TBL] [Abstract][Full Text] [Related]
4. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Chiang BJ; Kuo HC; Liao CH
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
[TBL] [Abstract][Full Text] [Related]
5. Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia-A Spotlight in Reality.
Hsu YC; Wang HJ; Chuang YC
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128942
[TBL] [Abstract][Full Text] [Related]
6. Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia.
Chuang YC; Chiang PH; Yoshimura N; De Miguel F; Chancellor MB
BJU Int; 2006 Nov; 98(5):1033-7; discussion 1337. PubMed ID: 16956361
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive therapy of lower urinary tract symptoms.
Donnell RF
Urol Clin North Am; 2009 Nov; 36(4):497-509, vi-vii. PubMed ID: 19942048
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for the lower urinary tract.
Chuang YC; Kuo HC; Chancellor MB
BJU Int; 2010 Apr; 105(8):1046-58. PubMed ID: 22299133
[TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin A for benign prostatic hyperplasia.
Oeconomou A; Madersbacher H
Curr Opin Urol; 2010 Jan; 20(1):28-36. PubMed ID: 19887944
[TBL] [Abstract][Full Text] [Related]
10. Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trial.
Robert G; Descazeaud A; Karsenty G; Saussine C; Azzouzi AR; de la Taille A; Desgrandchamps F; Faix A; Fourmarier M; Georget A; Benard A; Barry Delongchamps N
World J Urol; 2018 Jun; 36(6):921-929. PubMed ID: 29383480
[TBL] [Abstract][Full Text] [Related]
11. The application of botulinum toxin in the prostate.
Chuang YC; Chancellor MB
J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
[TBL] [Abstract][Full Text] [Related]
12. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
Luvisetto S; Gazerani P; Cianchetti C; Pavone F
Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
[TBL] [Abstract][Full Text] [Related]
13. International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction.
Esquenazi A; Novak I; Sheean G; Singer BJ; Ward AB
Eur J Neurol; 2010 Aug; 17 Suppl 2():1-8. PubMed ID: 20633176
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin A in prostate disease: a venom from bench to bed-side.
Mearini L; Giannantoni A
Curr Drug Deliv; 2012 Jan; 9(1):85-94. PubMed ID: 22409179
[TBL] [Abstract][Full Text] [Related]
15. [Use of botulinum neurotoxin for spasticity].
Mukai Y; Kaji R
Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
17. Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms.
Magistro G; Chapple CR; Elhilali M; Gilling P; McVary KT; Roehrborn CG; Stief CG; Woo HH; Gratzke C
Eur Urol; 2017 Dec; 72(6):986-997. PubMed ID: 28734706
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
Sycha T; Kranz G; Auff E; Schnider P
J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of botulinum neurotoxin: Unexpected consequences.
Hallett M
Toxicon; 2018 Jun; 147():73-76. PubMed ID: 28803760
[TBL] [Abstract][Full Text] [Related]
20. [What role does botulinum toxin play in the treatment of benign prostatic hyperplasia?].
Mazdar A; Bedouche A; Zoughari S; Ibrahimi A; Sayegh HE; Iken A; Benslimane L; Nouini Y
Pan Afr Med J; 2016; 24():309. PubMed ID: 28154664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
